Terms: = Pancreatic cancer AND PDGFB, SIS, 5155, ENSG00000100311, FLJ12858, PDGF2, P01127, c-sis, SSV AND Prognosis
5 results:
1. A novel investigation into the negative impact of opioid use on the efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer patients.
Guo H; Li Y; Lin J; Li D; Yang J; Wang J; Mao J; Wang Y; Yan X
Int Immunopharmacol; 2024 Mar; 129():111611. PubMed ID: 38325047
[TBL] [Abstract] [Full Text] [Related]
2. Prognostic Impact of the Preoperative Systemic Inflammation Score in Patients With pancreatic Ductal Adenocarcinoma.
Iguchi T; Iseda N; Hirose K; Itoh S; Harada N; Ninomiya M; Sugimachi K; Honboh T; Maeda T; Sadanaga N; Matsuura H
Am Surg; 2023 Jun; 89(6):2213-2219. PubMed ID: 35392670
[TBL] [Abstract] [Full Text] [Related]
3. Combined systemic inflammation score (sis) correlates with prognosis in patients with advanced pancreatic cancer receiving palliative chemotherapy.
Markus M; Abendroth A; Noureddine R; Paul A; Breitenbuecher S; Virchow I; Schmid KW; Markus P; Schumacher B; Wiesweg M; Wendling J; Mende B; Siveke JT; Schuler M; Kasper S
J Cancer Res Clin Oncol; 2021 Feb; 147(2):579-591. PubMed ID: 32839836
[TBL] [Abstract] [Full Text] [Related]
4. PDGFRβ expression in tumor stroma of pancreatic adenocarcinoma as a reliable prognostic marker.
Yuzawa S; Kano MR; Einama T; Nishihara H
Med Oncol; 2012 Dec; 29(4):2824-30. PubMed ID: 22403002
[TBL] [Abstract] [Full Text] [Related]
5. Oncogene expression in endocrine pancreatic tumors.
Höfler H; Ruhri C; Pütz B; Wirnsberger G; Hauser H
Virchows Arch B Cell Pathol Incl Mol Pathol; 1988; 55(6):355-61. PubMed ID: 2904191
[TBL] [Abstract] [Full Text] [Related]
